Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

190
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
190
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

283
Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
283
Study Designs in Epidemiology01:20

Study Designs in Epidemiology

1.2K
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.2K
Dosage Regimens: Designs and Approaches01:28

Dosage Regimens: Designs and Approaches

392
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
392

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Effects of repeated culture in sub-inhibitory concentrations of ciprofloxacin on resistance and genetic characteristics of an ocular Pseudomonas aeruginosa isolate.

World journal of microbiology & biotechnology·2026
Same author

A pilot study on the effect of the exoU gene on biofilm formation by a strain of Pseudomonas aeruginosa isolated from microbial keratitis.

Experimental eye research·2026
Same author

Corrigendum to "TFOS DEWS III: Digest" Am J Ophthalmol. 2025; 279:451-553.

American journal of ophthalmology·2026
Same author

Should Daily Disposable Silicone Hydrogel Contact Lens Use be Considered as the First Choice Among Soft Contact Lens Options for Pediatric Myopia Control?

Eye & contact lens·2026
Same author

Diurnal Variation, Topographical Distribution and Day-to-Day Repeatability of Ocular Surface Epithelial Immune Cells in Individuals with Dry Eye Disease.

Journal of clinical medicine·2026
Same author

Stakeholder Perspectives of Implementation Barriers of Artificial Intelligence in Eye Care: A qualitative framework-based study.

Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists)·2026
Same journal

A post-HSCT ocular surface "Window of Opportunity for Pre-emptive ocular treatment" (WinOP) shows early inflammatory activation and an oGVHD-like molecular subset.

The ocular surface·2026
Same journal

Pipeline: Eugene Garfield, Ph.D. and Bibliometrics.

The ocular surface·2026
Same journal

The ocular surface consequences of lacrimal gland loss are life-stage dependent.

The ocular surface·2026
Same journal

Evaluating synthetic anterior segment images for transferable eye disease recognition.

The ocular surface·2026
Same journal

Beyond diagnosis: AI-based surgical risk assessment in Acanthamoeba keratitis with real-world validation.

The ocular surface·2026
Same journal

Impact of the loss of tenascin X on tissue architecture and wound healing of the murine corneal stroma.

The ocular surface·2026
See all related articles

Related Experiment Video

Updated: Feb 26, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K

TFOS DEWS II Clinical Trial Design Report.

Gary D Novack1, Penny Asbell2, Stefano Barabino3

  • 1Pharma Logic Development, San Rafael, CA, USA; Departments of Pharmacology and Ophthalmology, University of California, Davis, School of Medicine, CA, USA.

The Ocular Surface
|July 25, 2017
PubMed
Summary
This summary is machine-generated.

Developing new Dry Eye Disease (DED) therapies is challenging due to trial complexities. The report emphasizes rigorous Good Clinical Practice (GCP) and Good Manufacturing Practice (GMP) standards for future DED treatment trials.

Keywords:
BiostatisticsClinical trial designClinical trialsDry eye diseaseRegulatory affairs

More Related Videos

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.8K
Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

8.6K

Related Experiment Videos

Last Updated: Feb 26, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.4K
Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research
08:33

Author Spotlight: Methodologies and Advancements of Chronic Pain Management Research

Published on: January 5, 2024

1.8K
Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability
08:22

Remotely Supervised Transcranial Direct Current Stimulation: An Update on Safety and Tolerability

Published on: October 7, 2017

8.6K

Area of Science:

  • Ophthalmology
  • Clinical Trial Design
  • Regulatory Science

Background:

  • Developing novel Dry Eye Disease (DED) therapies faces significant hurdles, with few treatments achieving marketing approval.
  • Numerous clinical trials for DED have failed, with no single clear reason identified, though a lack of sign-symptom correlation is noted.

Purpose of the Study:

  • To review challenges in designing and conducting quality clinical trials for DED.
  • To present the regulatory perspective on DED therapies.
  • To advocate for improved trial methodologies and standards.

Main Methods:

  • Literature review and analysis of challenges in DED clinical trials.
  • Examination of regulatory considerations for DED therapeutics.
  • Subcommittee review of trial design and execution issues.

Main Results:

  • Identified lack of correlation between clinical signs and patient symptoms as a key issue in DED trials.
  • Highlighted the need for high-quality studies adhering to established guidelines.
  • Emphasized the importance of consistent trial design, treatment, and sample size.

Conclusions:

  • Future DED trials must adhere strictly to Good Clinical Practice (GCP) and Good Manufacturing Practice (GMP).
  • Consistent and appropriate study design, including outcome measure selection and sample size, is crucial for pivotal studies.
  • Improved trial conduct is essential for advancing DED therapeutic development.